METTL3 and atherosclerosis: Li et al. found that the expression of METTL3 in macrophages increased with the progression of atherosclerosis and METTL3 targets BRAF mRNA and promoted its translation through YTHDF1, exacerbating macrophage-mediated inflammatory responses and atherosclerotic progression (18).